135 related articles for article (PubMed ID: 15910504)
1. Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma.
Tan L; Fu XY; Liu SQ; Li HH; Hong Y; Wu MC; Wang HY
Liver Int; 2005 Jun; 25(3):667-76. PubMed ID: 15910504
[TBL] [Abstract][Full Text] [Related]
2. The role of p28GANK in rat oval cells activation and proliferation.
Shan YF; Zhou WP; Fu XY; Yan HX; Yang W; Liu SQ; Cao HF; Kang B; Wu MC; Wang HY
Liver Int; 2006 Mar; 26(2):240-7. PubMed ID: 16448463
[TBL] [Abstract][Full Text] [Related]
3. p28GANK inhibits endoplasmic reticulum stress-induced cell death via enhancement of the endoplasmic reticulum adaptive capacity.
Dai RY; Chen Y; Fu J; Dong LW; Ren YB; Yang GZ; Qian YW; Cao J; Tang SH; Yang SL; Wang HY
Cell Res; 2009 Nov; 19(11):1243-57. PubMed ID: 19736567
[TBL] [Abstract][Full Text] [Related]
4. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
[TBL] [Abstract][Full Text] [Related]
5. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
[TBL] [Abstract][Full Text] [Related]
6. IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.
Yumoto E; Nakatsukasa H; Hanafusa T; Yumoto Y; Nouso K; Matsumoto E; Onishi T; Takuma Y; Tanaka H; Fujikawa T; Suzuki M; Uemura M; Shiratori Y
Int J Oncol; 2005 Nov; 27(5):1223-30. PubMed ID: 16211216
[TBL] [Abstract][Full Text] [Related]
7. Cellular retinol-binding protein-1 in hepatocellular carcinoma correlates with beta-catenin, Ki-67 index, and patient survival.
Schmitt-Gräff A; Ertelt V; Allgaier HP; Koelble K; Olschewski M; Nitschke R; Bochaton-Piallat ML; Gabbiani G; Blum HE
Hepatology; 2003 Aug; 38(2):470-80. PubMed ID: 12883492
[TBL] [Abstract][Full Text] [Related]
8. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
[TBL] [Abstract][Full Text] [Related]
9. Identification of c-Yes expression in the nuclei of hepatocellular carcinoma cells: involvement in the early stages of hepatocarcinogenesis.
Nonomura T; Masaki T; Morishita A; Jian G; Uchida N; Himoto T; Izuishi K; Iwama H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2007 Jan; 30(1):105-11. PubMed ID: 17143518
[TBL] [Abstract][Full Text] [Related]
10. High-throughput tissue microarray analysis of c-myc activation in chronic liver diseases and hepatocellular carcinoma.
Chan KL; Guan XY; Ng IO
Hum Pathol; 2004 Nov; 35(11):1324-31. PubMed ID: 15668888
[TBL] [Abstract][Full Text] [Related]
11. [The effects of p16 and Rb protein expression and NF-kappaB activity on hepatocarcinogenesis].
Wang ZW; Peng ZH; Tang HM; Qiu GQ; Xing TH; Yang MZ
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):225-8. PubMed ID: 15059540
[TBL] [Abstract][Full Text] [Related]
12. Expression of MAGE-1 and -3 genes and gene products in human hepatocellular carcinoma.
Kariyama K; Higashi T; Kobayashi Y; Nouso K; Nakatsukasa H; Yamano T; Ishizaki M; Kaneyoshi T; Toshikuni N; Ohnishi T; Fujiwara K; Nakayama E; Terracciano L; Spagnoli GC; Tsuji T
Br J Cancer; 1999 Nov; 81(6):1080-7. PubMed ID: 10576668
[TBL] [Abstract][Full Text] [Related]
13. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.
Koga H; Sakisaka S; Ohishi M; Kawaguchi T; Taniguchi E; Sasatomi K; Harada M; Kusaba T; Tanaka M; Kimura R; Nakashima Y; Nakashima O; Kojiro M; Kurohiji T; Sata M
Hepatology; 1999 Mar; 29(3):688-96. PubMed ID: 10051469
[TBL] [Abstract][Full Text] [Related]
14. Wilms' tumour 1 gene expression is increased in hepatocellular carcinoma and associated with poor prognosis.
Sera T; Hiasa Y; Mashiba T; Tokumoto Y; Hirooka M; Konishi I; Matsuura B; Michitaka K; Udaka K; Onji M
Eur J Cancer; 2008 Mar; 44(4):600-8. PubMed ID: 18255279
[TBL] [Abstract][Full Text] [Related]
15. The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling.
Dong LW; Yang GZ; Pan YF; Chen Y; Tan YX; Dai RY; Ren YB; Fu J; Wang HY
Cell Res; 2011 Aug; 21(8):1248-61. PubMed ID: 21691299
[TBL] [Abstract][Full Text] [Related]
16. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy.
Sieghart W; Losert D; Strommer S; Cejka D; Schmid K; Rasoul-Rockenschaub S; Bodingbauer M; Crevenna R; Monia BP; Peck-Radosavljevic M; Wacheck V
J Hepatol; 2006 Jan; 44(1):151-7. PubMed ID: 16289418
[TBL] [Abstract][Full Text] [Related]
17. Relationship between p53 overexpression and the proliferative activity in hepatocellular carcinoma.
Itoh T; Shiro T; Seki T; Nakagawa T; Wakabayashi M; Inoue K; Okamura A
Int J Mol Med; 2000 Aug; 6(2):137-42. PubMed ID: 10891556
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
[TBL] [Abstract][Full Text] [Related]
19. Expression of the transcription factor Klf6 in cirrhosis, macronodules, and hepatocellular carcinoma.
Bureau C; Péron JM; Bouisson M; Danjoux M; Selves J; Bioulac-Sage P; Balabaud C; Torrisani J; Cordelier P; Buscail L; Vinel JP
J Gastroenterol Hepatol; 2008 Jan; 23(1):78-86. PubMed ID: 18171345
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma.
Kanda K; Nakayama T; Onizuka S; Tomioka T; Kanematsu T
Hepatogastroenterology; 2002; 49(45):747-51. PubMed ID: 12063983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]